McLeod HL - Search Results

1

Impact of genotype-guided dosing on anticoagulation visits for adults starting warfarin: a randomized controlled trial.

Jonas DE, Evans JP, McLeod HL, Brode S, Lange LA, Young ML, Shilliday BB, Bardsley MM, Swinton-Jenkins NJ, Weck KE. Jonas DE, et al. Among authors: mcleod hl. Pharmacogenomics. 2013 Oct;14(13):1593-603. doi: 10.2217/pgs.13.145. Pharmacogenomics. 2013. PMID: 24088130 Clinical Trial.

2

Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations.

Ferrell PB Jr, McLeod HL. Ferrell PB Jr, et al. Among authors: mcleod hl. Pharmacogenomics. 2008 Oct;9(10):1543-6. doi: 10.2217/14622416.9.10.1543. Pharmacogenomics. 2008. PMID: 18855540 Free PMC article.

3

Race does not explain genetic heterogeneity in pharmacogenomic pathways.

Yen-Revollo JL, Auman JT, McLeod HL. Yen-Revollo JL, et al. Among authors: mcleod hl. Pharmacogenomics. 2008 Nov;9(11):1639-45. doi: 10.2217/14622416.9.11.1639. Pharmacogenomics. 2008. PMID: 19018720 Free PMC article.

4

Estimation of the warfarin dose with clinical and pharmacogenetic data.

International Warfarin Pharmacogenetics Consortium; Klein TE, Altman RB, Eriksson N, Gage BF, Kimmel SE, Lee MT, Limdi NA, Page D, Roden DM, Wagner MJ, Caldwell MD, Johnson JA. International Warfarin Pharmacogenetics Consortium, et al. N Engl J Med. 2009 Feb 19;360(8):753-64. doi: 10.1056/NEJMoa0809329. N Engl J Med. 2009. PMID: 19228618 Free PMC article.

5

Validation of clinical testing for warfarin sensitivity: comparison of CYP2C9-VKORC1 genotyping assays and warfarin-dosing algorithms.

Langley MR, Booker JK, Evans JP, McLeod HL, Weck KE. Langley MR, et al. Among authors: mcleod hl. J Mol Diagn. 2009 May;11(3):216-25. doi: 10.2353/jmoldx.2009.080123. Epub 2009 Mar 26. J Mol Diagn. 2009. PMID: 19324988 Free PMC article.

6

Genetic and clinical factors relating to warfarin dosing.

Jonas DE, McLeod HL. Jonas DE, et al. Among authors: mcleod hl. Trends Pharmacol Sci. 2009 Jul;30(7):375-86. doi: 10.1016/j.tips.2009.05.001. Epub 2009 Jun 17. Trends Pharmacol Sci. 2009. PMID: 19540002 Review.

7

Influence of ethnicity on pharmacogenetic variation in the Ghanaian population.

Yen-Revollo JL, Van Booven DJ, Peters EJ, Hoskins JM, Engen RM, Kannall HD, Ofori-Adjei D, McLeod HL, Marsh S. Yen-Revollo JL, et al. Among authors: mcleod hl. Pharmacogenomics J. 2009 Dec;9(6):373-9. doi: 10.1038/tpj.2009.28. Epub 2009 Jun 23. Pharmacogenomics J. 2009. PMID: 19546880

8

Pharmacodynamic genes do not influence risk of neutropenia in cancer patients treated with moderately high-dose irinotecan.

Hoskins JM, Rosner GL, Ratain MJ, McLeod HL, Innocenti F. Hoskins JM, et al. Among authors: mcleod hl. Pharmacogenomics. 2009 Jul;10(7):1139-46. doi: 10.2217/pgs.09.35. Pharmacogenomics. 2009. PMID: 19604089 Free PMC article.

9

Using germline genotype in cancer pharmacogenetic studies.

McWhinney SR, McLeod HL. McWhinney SR, et al. Among authors: mcleod hl. Pharmacogenomics. 2009 Mar;10(3):489-93. doi: 10.2217/14622416.10.3.489. Pharmacogenomics. 2009. PMID: 19650256 Free PMC article. Review.

10

Clopidogrel pharmacogenomics and risk of inadequate platelet inhibition: US FDA recommendations.

Ellis KJ, Stouffer GA, McLeod HL, Lee CR. Ellis KJ, et al. Among authors: mcleod hl. Pharmacogenomics. 2009 Nov;10(11):1799-817. doi: 10.2217/pgs.09.143. Pharmacogenomics. 2009. PMID: 19891556 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

588 results

Search Page